menu
    • menu

    Company profile for Voltron Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Voltron Therapeutics, Inc. is improving cell mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, using the advanced and proprietary VaxCelerate™ Self-Assembling Vaccine Design developed by specialists at the Massachusetts General Hospital (MGH) and the Vaccine & Immunotherapy Center. Voltron has an exclusive license to this technology from MGH.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Voltron TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    575 Fifth Avenue, 14th Floor, New York, NY 10019, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://voltrontx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Voltron Announces Completion of Trial Protocol to Study Self Assembling Vaccine
    Voltron Announces Completion of Trial Protocol to Study Self Assembling Vaccine

    20 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lucius-partners-portfolio-company-voltron-therapeutics-inc-announces-completion-of-a-trial-protocol-to-study-its-self-assembling-vaccine-to-target-prostate-stem-cell-antigen-301993785.html

    PR NEWSWIRE
    20 Nov 2023
    Share Share
    Voltron Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection
    Voltron Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection

    26 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/voltron-therapeutics-inc-a-lucius-partners-portfolio-company-announces-data-demonstrating-vaxcelerate-vaccine-induced-protection-against-viral-pathogens-301938363.html

    PR NEWSWIRE
    26 Sep 2023
    Share Share
    Voltron Announces Agreement with the Massachusetts General Hospital
    Voltron Announces Agreement with the Massachusetts General Hospital

    28 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lucius-partners-portfolio-company-voltron-therapeutics-inc-announces-sponsored-research-agreement-with-the-massachusetts-general-hospital-harvard-medical-school-to-initiate-a-pre-clinical-immuno-oncology-trial-301758193.html

    PR NEWSWIRE
    28 Feb 2023
    Share Share
    Voltron Announces Presentation at Military Health System Research Symposium
    Voltron Announces Presentation at Military Health System Research Symposium

    26 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/voltron-therapeutics-inc-a-lucius-partners-portfolio-company-announces-poster-presentation-at-the-military-health-system-research-symposium-301659727.html

    PRNEWSWIRE
    26 Oct 2022
    Share Share
    Voltron Tx Announces Definitive Proof of Concept Data for VTX-067
    Voltron Tx Announces Definitive Proof of Concept Data for VTX-067

    14 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/voltron-therapeutics-inc-a-lucius-partners-portfolio-company-announces-definitive-proof-of-concept-data-for-its-lead-oncology-candidate-vtx-067-in-an-hpv-related-tumor-challenge-study-301586871.html

    PRNEWSWIRE
    14 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search